Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Jane sold 2,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 17, 2026

On Apr 16, 2026, Henderson Jane (Chief Financial Officer) sold 2,000 Apogee Therapeutics, Inc. shares at US$90.00 for US$180K under a trading plan, leaving 175,371 shares. Filed Apr 17, 2026 (Form 4).

Sold
2,000 shares
Price
US$90.00
Value
US$180K
Holding after
175,371 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockSale2,000US$90.00175,371Direct

Source

View original at SEC

Related